• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Evaluating recent trends in early measles vaccinations in Texas

Evaluating recent trends in early measles vaccinations in Texas

by Truveta Research | May 16, 2025 | Research, Research Insights

Among children in Texas receiving a first measles vaccine prior to two years of life: In March and April 2025, 20.1% of all first measles vaccines were administered to children early (6-11 months). This is 11.5-fold higher than in 2019, when there were international...

Share this


Recent posts

  • Truveta Experts: Real-world trends in Rituxan biosimilar adoption
  • Shifting trends in initiation of disease-modifying therapies for multiple sclerosis
  • New AAP guidelines are changing pediatric obesity treatment—but there’s still work to do

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.